At a Glance

  • PCT: growing business providing development, manufacturing and delivery of cell-based therapies - Averaging 25% year-over-year revenue growth over past two years - Unmatched cell and cell-based gene therapy-specific experience and expertise - Expansive list of noteworthy cell and cell-based gene therapy clients
  • Focused pipeline of highly promising cell therapies - Leverages internal specialized cell therapy clinical development expertise and PCT’s CMC prowess - Partnering post-POC provides value inflection and an additional stream of new PCT clients - CLBS03 – Treg cell therapy targeting adolescents with recent-onset type 1 diabetes
  • Highly experienced management and domain-specific scientific team

Stock Chart

Maximum 30 minute delay for quote.

Sign up to our e-mail list to receive Caladrius announcements.

  • logo-cirm-2_0

    CIRM Bridges Meeting

    • Date and Time: Monday, July 18, 2016, 4:30 PM PT
    • Venue: Claremont Club & Spa, Berkeley, California
    • Topic: Succeeding for the Patient: Meeting Manufacturing Demands of Advanced Therapies
    • Presenter: Robert A. Preti, PhD, Senior Vice President, Manufacturing and Technical Operations and Chief Technology Officer of Caladrius; President, PCT
  • Crossroads

    Regenerative Medicine Crossroad

    • Date and Time: Thursday, July 28, 2016, 1:50 PM JST
    • Website: https://firm.or.jp/rmit/archives/162
    • Venue: Nihonbashi Life Science Building, Tokyo, Japan
    • Topic: Autologous CD34 Cell Therapy for Treatment of Critical Limb Ischemia Under PMDA Agreement
    • Presenter: Douglas W. Losordo, MD, Senior Vice President Clinical, Medical and Regulatory Affairs and Chief Medical Officer of Caladrius
  • Caladrius Biosciences Logo

    Second Quarter 2016 Financial Results

    Caladrius’ management hosted a conference call for the investment community beginning at 5:00 pm ET on Tuesday, August 9, 2016, to discuss the financial results, provide a company update and answer questions.

    A recording of the conference call can be accessed by playing the file below:

  • brm-2016-logo2-w600px

    Business of Regenerative Medicine: How to Build a Company

    • Date and Time: Monday, July 11, 2016, 2:00 PM ET
    • Website: http://hsci.harvard.edu/event/brm_2016
    • Venue: Harvard Business School, Cambridge, Massachusetts
    • Topic: Building the Future: Advanced Therapies & Scalability
    • Presenter: Robert A. Preti, PhD, Senior Vice President, Manufacturing and Technical Operations and Chief Technology Officer of Caladrius; President, PCT
  • isscr-2016

    ISSCR 2016 Annual Meeting

    • Date and Time: June 22, 2016, 7:30 PM PDT
    • Website: www.isscr.org/home/annual-meeting/san-francisco-2016
    • Venue: Moscone West, San Francisco, California
    • Poster Topic: CD34+CD45- Cells Isolated From Human Blood Have Molecular and Functional Characteristics of Endothelial Progenitors
    • Poster Presenter(s): Yajuan Jiang, PhD, Senior Scientist, Associate Director, PCT; David O’Neill, MD, Medical Director and Director, Analytical Development, PCT
    • Poster To Be Archived At: www.caladrius.com/ISSCR2016poster

Investor Relations Contact

Lippert/Heilshorn & Associates
Anne Marie Fields
Phone: +1-212-838-3777
E-mail: afields@lhai.com

Media Contact

Caladrius Biosciences, Inc.
Eric Powers
Director of Communications and Marketing
Phone: +1-212-584-4173
Email: epowers@caladrius.com